News

A significant number of applications for the first round of grants from the newly established European Research Council have come from senior scientists currently living in non-EU countries.

The claim that over-patenting hinders the development of new treatments is not supported by the evidence, says the US Biotechnology Industry Organization.

Novo Nordisk is doing its bit to reverse the Danish brain drain, offering a number of “return” fellowships to attract highly qualified expatriates back to Denmark.